Ameritas Advisory Services’s Benitec Biopharma BNTC Stock Holding History
Bought
Maintained
Sold
Other funds holding BNTC
Ameritas Advisory Services's BNTC Position: Q1 2019 in Review
Ameritas Advisory Services sold out of Benitec Biopharma (BNTC) in Q1 2019, closing a stake of 8 shares — an estimated $3K sold.
Ameritas Advisory Services first reported a position in BNTC in Q4 2018 and held it in 1 quarter. The position peaked at $3K in Q4 2018. 6 funds tracked by Wall St. Rank hold BNTC as of Q1 2019.
- Ameritas Advisory Services reported no remaining Benitec Biopharma position as of Q1 2019 after selling out during the quarter.
- Ameritas Advisory Services sold 8 Benitec Biopharma shares in Q1 2019, an estimated $3K.
- Ameritas Advisory Services first reported a position in Benitec Biopharma in Q4 2018 and held it in 1 quarter.
- Ameritas Advisory Services's Benitec Biopharma position peaked at $3K in Q4 2018.
- 6 funds tracked by Wall St. Rank held Benitec Biopharma as of Q1 2019.
Based on Ameritas Advisory Services's 13F filing for Q1 2019, filed 16 May 2019.